2020 Partners
CanET
The Cardiac Arrhythmia Network of Canada (CANet) is a Pan-Canadian multidisciplinary and multi-sectoral research and development network of investigators, well-positioned industry partners, patients, caregivers, and healthcare providers focused on research, technology development and commercialization, and digital transformation activities. CANet’s mission is to develop, evaluate, and implement innovative technologies and health strategies to improve arrhythmia health in Canada.
CCRM
CCRM is a leading biotechnology accelerator based in Toronto, Canada. CCRM translates scientific discovery into new companies and marketed products, with a specific focus on cell and gene therapy. Using a unique combination of international technology sourcing, specialized expertise and laboratory infrastructure, CCRM creates innovative spin-off companies and invests in promising ventures through our commercial arm, CCRM Enterprises.
CHEO Research institute
The Children’s Hospital of Eastern Ontario (CHEO) Research Institute coordinates the research activities of CHEO and is affiliated with the University of Ottawa. Its three programs of research are molecular biomedicine, health information technology, and evidence to practice research. Key themes include cancer, diabetes, obesity, mental health, emergency medicine, musculoskeletal health, electronic health information and privacy, and genetics of rare disease. The CHEO Research Institute makes discoveries today for healthier kids tomorrow.
FEDDEV Ontario
For more than 10 years, FedDev Ontario has actively worked to advance and diversify the southern Ontario economy through funding opportunities and business services that support innovation and growth in Canada’s most populous region. The Agency has delivered impressive results, which can be seen in southern Ontario businesses that are creating innovative technologies, improving their productivity, growing their revenues, and in the economic advancement of communities across the region.
innovacorp
Innovacorp is Nova Scotia’s early stage venture capital organization. It finds, funds and fosters innovative Nova Scotia start-ups that strive to change the world. Early stage investment is at the core of Innovacorp’s business model. The organization also gives entrepreneurs access to world-class incubation facilities, expert advice, and other support to accelerate their companies.
McGill university
McGill University is one of Canada's best-known institutions of higher learning and one of the leading universities in the world, recognized for the excellence of its teaching and research programs. McGill has a long tradition of innovation that includes the invention of the artificial blood cell. Today its professors are building the new field of epigenetics, and driving human achievement in every field imaginable.
Mcmaster university
MontrÉal InVIVO
Montréal InVivo is the Greater Montréal's Life Sciences and Health Technology Cluster (LSHT), a non-profit organization for economic development. It aims to create a business environment that fosters innovation and development of public and private organizations in the LSHT sector.
oirm
The Ontario Institute for Regenerative Medicine (OIRM) is a non-profit stem cell institute funded by the Ontario government and dedicated to transforming discoveries into clinical trials and cures. Through our commitment to collaboration and partnerships, we leverage our resources to fund and support promising advances. OIRM is a passionate champion for investigators and their patients as we build a healthier future for Ontario, Canada, and the world.
stem cell network
Tomorrow’s health is here. The Stem Cell Network (SCN) is a national non-profit that supports stem cell and regenerative medicine research, training the next generation of highly qualified personnel, and delivering outreach activities across Canada. SCN’s goal is to advance science from the lab to the clinic for the benefit of Canadians. SCN has been supported by the Government of Canada since inception in 2001. This strategic funding, valued at $118M has benefitted approximately 170 world-class research groups and 3,000 trainees and has catalyzed 19 clinical trials.
